Check These 3 Biotech Penny Stocks Out For Your Watchlist
If you’re looking for biotech penny stocks to buy, there are hundreds of options to choose from. And while it may seem simple, it can be quite an arduous process to find biotech stocks that are worth investing in. While we do have to do the typical research involved in buying any penny stocks, biotech stocks work quite differently.
[Read More] 3 Top Penny Stocks To Watch Before Next Week
For that reason, there are some extra steps to take. For one, biotech penny stocks remain highly speculative and volatile. This means that they are likely to move off of very little news. And, this news is typically related to drugs, trials, or upcoming announcements from the company.
While this can be a major benefit if prices go in the right direction, it can also cause dramatic losses if they go the other way. So, always make sure to understand exactly what is going on in the stock market and how to take advantage. With this in mind, let’s take a look at three biotech penny stocks to add to your watchlist right now.
3 Biotech Penny Stocks to Add to Your List Right Now
- Endo International Plc. (NASDAQ: ENDP)
- VBI Vaccines Inc. (NASDAQ: VBIV)
- Clovis Oncology Inc. (NASDAQ: CLVS)
Endo International Plc. (NASDAQ: ENDP)
One of the larger gainers of the day is ENDP stock, which shot up by over 12% and more than 5.5% during trading and after-hours respectively. A few days ago, the company announced that it entered into a commercialization agreement with TLC BioSciences for TLC599.
[Read More] Best Penny Stocks to Buy Right Now? 3 For Your Mid-June List
This is a proprietary BioSeizer sustained-release injectable that is currently in Phase 3 trials for osteoarthritis. In the agreement, TLC, will receive a payment of $30 million upfront and this could go up to $110 million in milestone payments.
“We are pleased to be adding another TLC product to Endo’s portfolio. We see tremendous opportunity in TLC599 to potentially address an unmet medical need in patients with osteoarthritis arthritis knee pain. If approved, we expect to launch this differentiated branded product in 2025.”
The CEO of Endo International, Blaise Coleman
Right now, there is a sizable amount of bullish sentiment in the biotech industry. And with ENDP, it’s clear that investors feel bullishly about the company. Whether it deserves a spot on your list of penny stocks to buy, is up to you.
VBI Vaccines Inc. (NASDAQ: VBIV)
During trading and after-hours on June 17th, VBIV climbed by over 1.3% and 1.6% respectively. The most recent news from the company came on June 6th when it announced updated Phase 2a Tumor response and overall survival data for its VBI-1901 in recurrent GBM.
“We continue to be motivated by the data seen in this Phase 2a study of VBI-1901 as we endeavor to provide new treatment options to patients with very few available to them.
Considering the high mortality rate among GBM patients, particularly in the recurrent setting, median overall survival of approximately 13-15 months seen in our two study arms suggests an additional survival benefit of nearly six months in comparison with historical control data in the recurrent population after treatment with a monotherapy.
The Chief Scientific Officer for VBI Vaccines, David E. Anderson
As stated earlier, there is a lot of investor interest in the biotech industry. And as a result, VBIV is seeing heightened bullish movement right now. So, with all of this in mind, do you think it deserves a spot on your penny stocks watchlist or not?
Clovis Oncology Inc. (NASDAQ: CLVS)
One of the largest gainers on June 17th is CLVS stock. At EOD, shares of CLVS had shot up by a very respectable 31%. And if that seems like a lot, in the past five days, we’ve seen shares of CLVS stock climb by more than 75%. As a result, many investors are wondering why CLVS stock is climbing so much right now. While we do see penny stocks climb with little to no news, on June 15th, the company made an exciting announcement. It announced important data from its Phase 1 trial study LuMIERE for FAP-2286.
In the presentation, the company stated that nine patients were treated, and of these, the company saw favorable safety data. Now, the company is working on recruitment for the third dose cohort. With this positive news, it makes sense that Clovis Oncology would see heightened interest from investors. Whether this makes it a buy or not, is up to you.
Which Penny Stocks Are You Watching Right Now?
Finding the best penny stocks to buy can be tricky. And with so much going on in the stock market right now, investors need to stay on their toes. In 2022, we have factors such as rising inflation, climbing interest rates, and much more.
[Read More] 5 Penny Stocks To Watch With High Short Interest, Are They A Buy Now?
All of this has contributed to the stock market being extremely volatile as of late. So, always make sure to understand exactly what is going on as this will be your best way to take advantage of market momentum. Considering this, which penny stocks are you watching right now?
[reblex id='29520']
